Search research articles
Contact Us
Filters
Showing results (131-140 of 219) with videos related to
Page
of 22
Sort By:
Toxicology Communications
|
March 26, 2021
Brodifacoum pharmacokinetics in acute human poisoning: implications for estimating duration of vitamin K therapy
Daniel G Nosal, Richard B van Breemen, John W Haffner, et al.
Journal of Neurochemistry
|
March 31, 2007
Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents
Kudret Tureyen, Ramya Kapadia, Kellie K Bowen, et al.
Drugs in R&D
|
January 29, 2019
Should Cytochrome P450 Inducers be Used to Accelerate Clearance of Brodifacoum from Poisoned Patients?
Israel Rubinstein, Richard van Breemen, Daniel G Nosal, et al.
Biochemical Pharmacology
|
June 1, 2005
Receptor-independent actions of PPAR thiazolidinedione agonists: is mitochondrial function the key?
D L Feinstein, A Spagnolo, C Akar, et al.
Journal of Neuroimmunology
|
January 24, 2012
Rapamycin reduces clinical signs and neuropathic pain in a chronic model of experimental autoimmune encephalomyelitis
L Lisi, P Navarra, R Cirocchi, et al.
Journal of Neurochemistry
|
April 5, 2003
Noradrenergic depletion increases inflammatory responses in brain: effects on IkappaB and HSP70 expression
Michael T Heneka, Vitaliy Gavrilyuk, Gary E Landreth, et al.
Pain
|
January 14, 2022
Conditional knockout of CRMP2 in neurons, but not astrocytes, disrupts spinal nociceptive neurotransmission to control the initiation and maintenance of chronic neuropathic pain
Lisa Boinon, Jie Yu, Cynthia L Madura, et al.
The Journal of Biological Chemistry
|
July 26, 1996
Heat shock protein 70 suppresses astroglial-inducible nitric-oxide synthase expression by decreasing NFkappaB activation
D L Feinstein, E Galea, D A Aquino, et al.
Journal of Neuroimmunology
|
January 29, 2013
IgM to S-nitrosylated protein is found intrathecally in relapsing-remitting multiple sclerosis
Charlotte Hvaring, Snezana Vujicic, Jan O Aasly, et al.
Journal of Neuroimmunology
|
November 6, 2012
The novel HSP90 inhibitor, PU-H71, suppresses glial cell activation but weakly affects clinical signs of EAE
Lucia Lisi, Susan McGuire, Anthony Sharp, et al.
Page
of 22
Search research articles
Search
Showing results (131-140 of 219) with videos related to
Sort By:
Page
of 22
Toxicology Communications
|
March 26, 2021
Brodifacoum pharmacokinetics in acute human poisoning: implications for estimating duration of vitamin K therapy
Daniel G Nosal, Richard B van Breemen, John W Haffner, et al.
Journal of Neurochemistry
|
March 31, 2007
Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents
Kudret Tureyen, Ramya Kapadia, Kellie K Bowen, et al.
Drugs in R&D
|
January 29, 2019
Should Cytochrome P450 Inducers be Used to Accelerate Clearance of Brodifacoum from Poisoned Patients?
Israel Rubinstein, Richard van Breemen, Daniel G Nosal, et al.
Biochemical Pharmacology
|
June 1, 2005
Receptor-independent actions of PPAR thiazolidinedione agonists: is mitochondrial function the key?
D L Feinstein, A Spagnolo, C Akar, et al.
Journal of Neuroimmunology
|
January 24, 2012
Rapamycin reduces clinical signs and neuropathic pain in a chronic model of experimental autoimmune encephalomyelitis
L Lisi, P Navarra, R Cirocchi, et al.
Journal of Neurochemistry
|
April 5, 2003
Noradrenergic depletion increases inflammatory responses in brain: effects on IkappaB and HSP70 expression
Michael T Heneka, Vitaliy Gavrilyuk, Gary E Landreth, et al.
Pain
|
January 14, 2022
Conditional knockout of CRMP2 in neurons, but not astrocytes, disrupts spinal nociceptive neurotransmission to control the initiation and maintenance of chronic neuropathic pain
Lisa Boinon, Jie Yu, Cynthia L Madura, et al.
The Journal of Biological Chemistry
|
July 26, 1996
Heat shock protein 70 suppresses astroglial-inducible nitric-oxide synthase expression by decreasing NFkappaB activation
D L Feinstein, E Galea, D A Aquino, et al.
Journal of Neuroimmunology
|
January 29, 2013
IgM to S-nitrosylated protein is found intrathecally in relapsing-remitting multiple sclerosis
Charlotte Hvaring, Snezana Vujicic, Jan O Aasly, et al.
Journal of Neuroimmunology
|
November 6, 2012
The novel HSP90 inhibitor, PU-H71, suppresses glial cell activation but weakly affects clinical signs of EAE
Lucia Lisi, Susan McGuire, Anthony Sharp, et al.
Page
of 22